Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
BlueLinx Holdings Inc. (BXC - Free Report) : This the largest distributor of building products in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 71.4% over the last 60 days.
Cambium Networks Corporation (CMBM - Free Report) : This company that provides wireless broadband networking infrastructure solutions for network operators has seen the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Central Garden & Pet Company (CENT - Free Report) : This company that produces and distributes products for the lawn and garden, and pet supplies markets in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 90 days.
NVR, Inc. (NVR - Free Report) : This company that engages in the construction and sale of single-family detached homes, townhomes and condominium buildings has seen the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
PACCAR Inc. (PCAR - Free Report) : This leading manufacturer of heavy-duty trucks in the world has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
BlueLinx Holdings Inc. (BXC - Free Report) : This the largest distributor of building products in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 71.4% over the last 60 days.
Cambium Networks Corporation (CMBM - Free Report) : This company that provides wireless broadband networking infrastructure solutions for network operators has seen the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Central Garden & Pet Company (CENT - Free Report) : This company that produces and distributes products for the lawn and garden, and pet supplies markets in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 90 days.
NVR, Inc. (NVR - Free Report) : This company that engages in the construction and sale of single-family detached homes, townhomes and condominium buildings has seen the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
PACCAR Inc. (PCAR - Free Report) : This leading manufacturer of heavy-duty trucks in the world has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PCAR - FREE
Get the latest research report on CENT - FREE
Get the latest research report on BXC - FREE
Get the latest research report on NVR - FREE
Get the latest research report on CMBM - FREE